Coleus forskohlii

Coleus forskohlii

Supplement Forms/Alternate Names:

Forskolin

Introduction

Coleus forskohlii is a plant in the mint family. Forskolin is a compound found in the root of the plant. Both have been used to improve eye health and promote weight loss. It can be taken as a pill, powder, or used as eye drops. It can also be inhaled under medical supervision and given by IV by a healthcare provider.

Dosages

250 milligrams 2 to 3 times daily

What Research Shows

May Be Effective

  • Glaucoma—may lower eye pressure when used with standard treatment B1-B3

Not Enough Data to Assess

Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.

Safety Notes

It may be safe to take small doses of coleus forskohlii for a short period of time. Not enough studies have been done to say whether it is safe to take for a long period or by those who are pregnant or breastfeeding.

Interactions

Talk to your doctor about any supplements or therapy you would like to use. Some can interfere with treatment or make conditions worse.

References

A. Asthma

A1. Huerta M, Urzúa Z, et al. Forskolin compared with beclomethasone for prevention of asthma attacks: a single-blind clinical trial. J Int Med Res. 2010 Mar-Apr;38(2):661-668.

B. Glaucoma

B1. Ventrugno M, Uva MG, et al. Oral administration of forskolin and rutin contributes to intraocular pressure control in primary open angle glaucoma patients under maximum tolerated medical therapy. J Ocul Pharmacol Ther. 2012;28(5):536-541.

B2. Nebbioso M, Rusciano D, et al. Treatment of glaucomatous patients by means of food supplement to reduce the ocular discomfort: a double blind randomized trial. Eur Rev Med Pharmacol Sci. 2013 Apr;17(8):1117-1122.

B3. Loskutova E, O'Brien C, et al. Nutritional supplementation in the treatment of glaucoma: A systematic review. Surv Ophthalmol. 2019 Mar -Apr;64(2):195-216.

C. Weight Loss

C1. Godard MP, Johnson BA, et al. Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men. Obes Res. 2005;13(8):1335-1343.

Last reviewed February 2020 by EBSCO NAT Review Board Eric Hurwitz, DC
Last Updated: 6/17/2020

EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days.

Home |Terms and Conditions |Concerned About Privacy? |Accessibility |Careers |For Employers and Medical Plan Providers

You may also be looking for: CVS/pharmacy | MinuteClinic | Specialty Pharmacy | SilverScript | Accordant